138 related articles for article (PubMed ID: 22130622)
1. DOK2 as a marker of poor prognosis of patients with gastric adenocarcinoma after curative resection.
Miyagaki H; Yamasaki M; Takahashi T; Kurokawa Y; Miyata H; Nakajima K; Takiguchi S; Fujiwara Y; Mori M; Doki Y
Ann Surg Oncol; 2012 May; 19(5):1560-7. PubMed ID: 22130622
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of RASSF6 is a novel independent prognostic marker of a worse outcome in gastric cancer patients after curative surgery.
Wen Y; Wang Q; Zhou C; Yan D; Qiu G; Yang C; Tang H; Peng Z
Ann Surg Oncol; 2011 Dec; 18(13):3858-67. PubMed ID: 21442347
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the prognostic value of a panel of tissue tumor markers and established clinicopathological factors in patients with gastric cancer.
Wiksten JP; Lundin J; Nordling S; Kokkola A; Haglund C
Anticancer Res; 2008; 28(4C):2279-87. PubMed ID: 18751407
[TBL] [Abstract][Full Text] [Related]
4. STAT3 expression in gastric cancer indicates a poor prognosis.
Kim DY; Cha ST; Ahn DH; Kang HY; Kwon CI; Ko KH; Hwang SG; Park PW; Rim KS; Hong SP
J Gastroenterol Hepatol; 2009 Apr; 24(4):646-51. PubMed ID: 19175826
[TBL] [Abstract][Full Text] [Related]
5. Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas.
Xue G; Hao LQ; Ding FX; Mei Q; Huang JJ; Fu CG; Yan HL; Sun SH
J Clin Gastroenterol; 2009 Oct; 43(9):831-7. PubMed ID: 19461527
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
[TBL] [Abstract][Full Text] [Related]
7. Reduced Krüppel-like factor 17 (KLF17) expression correlates with poor survival in patients with gastric cancer.
Peng JJ; Wu B; Xiao XB; Shao YS; Feng Y; Yin MX
Arch Med Res; 2014 Jul; 45(5):394-9. PubMed ID: 24947617
[TBL] [Abstract][Full Text] [Related]
8. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
9. erbB-2 expression in well-differentiated adenocarcinoma of the stomach predicts shorter survival after curative resection.
Motojima K; Furui J; Kohara N; Izawa K; Kanematsu T; Shiku H
Surgery; 1994 Mar; 115(3):349-54. PubMed ID: 7907434
[TBL] [Abstract][Full Text] [Related]
10. Prediction of sites of recurrence in gastric carcinoma using immunohistochemical parameters.
Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
J Surg Oncol; 2007 Feb; 95(2):123-8. PubMed ID: 17262742
[TBL] [Abstract][Full Text] [Related]
11. Fhit expression in gastric adenocarcinoma: correlation with disease stage and survival.
Capuzzi D; Santoro E; Hauck WW; Kovatich AJ; Rosato FE; Baffa R; Huebner K; McCue PA
Cancer; 2000 Jan; 88(1):24-34. PubMed ID: 10618602
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma.
Jüttner S; Wissmann C; Jöns T; Vieth M; Hertel J; Gretschel S; Schlag PM; Kemmner W; Höcker M
J Clin Oncol; 2006 Jan; 24(2):228-40. PubMed ID: 16344322
[TBL] [Abstract][Full Text] [Related]
13. Vimentin expression is associated with decreased survival in gastric cancer.
Otsuki S; Inokuchi M; Enjoji M; Ishikawa T; Takagi Y; Kato K; Yamada H; Kojima K; Sugihara K
Oncol Rep; 2011 May; 25(5):1235-42. PubMed ID: 21327330
[TBL] [Abstract][Full Text] [Related]
14. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
[TBL] [Abstract][Full Text] [Related]
15. Clinical implication and prognostic significance of the tumor suppressor TSLC1 gene detected in adenocarcinoma of the lung.
Uchino K; Ito A; Wakayama T; Koma Y; Okada T; Ohbayashi C; Iseki S; Kitamura Y; Tsubota N; Okita Y; Okada M
Cancer; 2003 Sep; 98(5):1002-7. PubMed ID: 12942568
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of perineural invasion in patients with gastric cancer who underwent curative resection.
Bilici A; Seker M; Ustaalioglu BB; Kefeli U; Yildirim E; Yavuzer D; Aydin FM; Salepci T; Oncel M; Gumus M
Ann Surg Oncol; 2010 Aug; 17(8):2037-44. PubMed ID: 20333555
[TBL] [Abstract][Full Text] [Related]
17. Low level of p27(Kip1) protein expression in gastric adenocarcinoma is associated with disease progression and poor outcome.
Nitti D; Belluco C; Mammano E; Marchet A; Ambrosi A; Mencarelli R; Segato P; Lise M
J Surg Oncol; 2002 Dec; 81(4):167-75; discussion 175-6. PubMed ID: 12451619
[TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma.
Chou YY; Jeng YM; Lee TT; Hu FC; Kao HL; Lin WC; Lai PL; Hu RH; Yuan RH
Ann Surg Oncol; 2007 Oct; 14(10):2748-58. PubMed ID: 17680316
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of osteopontin expression in human gastric carcinoma.
Higashiyama M; Ito T; Tanaka E; Shimada Y
Ann Surg Oncol; 2007 Dec; 14(12):3419-27. PubMed ID: 17896150
[TBL] [Abstract][Full Text] [Related]
20. Splenic hilar lymph node metastasis independently predicts poor survival for patients with gastric cancers in the upper and/or the middle third of the stomach.
Zhu GL; Sun Z; Wang ZN; Xu YY; Huang BJ; Xu Y; Zhu Z; Xu HM
J Surg Oncol; 2012 Jun; 105(8):786-92. PubMed ID: 22105768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
